This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
THE ADDITION AT DAY 9 OF HD‐MTX TO THE (DA)‐EPOCH SCHEME WITH OR WITHOUT RITUXIMAB IS AN EFFECTIVE REGIMEN IN UNTREATED ADVANCED STAGE HIGH RISK LYMPHOMA: A FEASIBILITY STUDY. (12th June 2019)
Record Type:
Journal Article
Title:
THE ADDITION AT DAY 9 OF HD‐MTX TO THE (DA)‐EPOCH SCHEME WITH OR WITHOUT RITUXIMAB IS AN EFFECTIVE REGIMEN IN UNTREATED ADVANCED STAGE HIGH RISK LYMPHOMA: A FEASIBILITY STUDY. (12th June 2019)
Main Title:
THE ADDITION AT DAY 9 OF HD‐MTX TO THE (DA)‐EPOCH SCHEME WITH OR WITHOUT RITUXIMAB IS AN EFFECTIVE REGIMEN IN UNTREATED ADVANCED STAGE HIGH RISK LYMPHOMA: A FEASIBILITY STUDY